Epifoam Aerosol, Foam
NDC Package 0037-6824-10
Package Information
Epifoam (pramoxine hydrochloride and hydrocortisone acetate) aerosols is this product contains 2 medications. This formulation utilizes a aerosol, foam delivery system. Marketed by Viatris Specialty Llc, this product is identified by NDC 0037-6824 and is authorized under FDA application ANDA086457.
Identification & Billing
- RxCUI: 904782 - hydrocortisone acetate 1 % / pramoxine HCl 1 % Topical Foam
- RxCUI: 904782 - hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Foam
- RxCUI: 904782 - hydrocortisone acetate 1 % / pramoxine hydrochloride 1 % Topical Foam
- RxCUI: 904783 - epifoam 1 % / 1 % Topical Foam
- RxCUI: 904783 - hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Foam [Epifoam]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0037 - Viatris Specialty Llc
- 0037-6824 - Epifoam
- 0037-6824-10 - 1 CANISTER in 1 CARTON / 10 g in 1 CANISTER
- 0037-6824 - Epifoam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0037-6824-10 identifies a specific commercial package of 1 canister in 1 carton / 10 g in 1 canister of Epifoam, a human prescription drug labeled by Viatris Specialty Llc. This aerosol, foam is formulated for topical use and contains hydrocortisone acetate; pramoxine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Viatris Specialty Llc on August 25, 2014. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product contains 2 medications. Pramoxine is an anesthetic that is used on the skin to relieve minor pain, itching, and discomfort. It works by temporarily numbing the area. Hydrocortisone is a corticosteroid that reduces redness, swelling, and itching. This combination medication is used to treat certain skin conditions such as eczema, psoriasis, rash, cuts, scrapes, insect bites, or minor burns. This product is available in different strengths and forms (e.g., aerosol foam, cream, ointment, lotion). The type of medication used depends on the location of your condition and the type of skin problem being treated. Creams are the most frequently used form. Lotions may be better for hairy areas. Ointments may be better for dry areas and when a stronger effect or skin protection is desired. Foams can be easier and less messy to apply.
How is this Viatris Specialty Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00037682410. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.